Effect of Tranexamic Acid in Upper Gastrointestinal Bleeding
Status:
Withdrawn
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that addition of Tranexamic acid, an antifibrinolytic agent, to
conventional therapy will lead to an improved outcome characterized by lower transfusion
requirements.